http://orcid.org/0000-0001-8268-8467
About the Authors
- Christophe Bauters
-
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
* E-mail: christophe.bauters@chru-lille.fr
Affiliation University of Lille, Inserm U1167, Institut Pasteur, University Hospital of Lille, Lille, France
- Emilie Dubois
-
Roles Conceptualization, Writing – review & editing
Affiliation University of Lille, Inserm U1167, Institut Pasteur, Lille, France
- Sina Porouchani
-
Roles Conceptualization, Writing – review & editing
Affiliation University Hospital of Lille, Lille, France
- Eric Saloux
-
Roles Conceptualization, Writing – review & editing
Affiliation University of Caen, EA 4650, University Hospital of Caen, Caen, France
- Marie Fertin
-
Roles Conceptualization, Writing – review & editing
Affiliation University Hospital of Lille, Lille, France
- Pascal de Groote
-
Roles Conceptualization, Writing – review & editing
Affiliation University of Lille, Inserm U1167, Institut Pasteur, University Hospital of Lille, Lille, France
- Nicolas Lamblin
-
Roles Conceptualization, Writing – original draft, Writing – review & editing
Affiliation University of Lille, Inserm U1167, Institut Pasteur, University Hospital of Lille, Lille, France
- Florence Pinet
-
Roles Conceptualization, Funding acquisition, Methodology, Writing – original draft
Affiliation University of Lille, Inserm U1167, Institut Pasteur, Lille, France
Competing Interests
Relationships with industry: C.B., travel grants from Amgen, Boehringer-Ingelheim, and MSD-Schering. E.S., consulting for Philips Research France; M.F., travel grants from Actelion, GlaxoSmithKline, MSD-Schering, Novartis, and consulting from Actelion, Novartis, and Vifor; P.d.G., fees for lectures or consulting from Actelion, Bayer, MSD-Schering, Novartis, Servier, Shire, and Vifor; N.L., research grant from Pfizer and fees for lectures or consulting from Actelion, Astra-Zeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, MSD-Schering, Novartis, Pfizer, and Sanofi-Aventis. This does not alter our adherence to PLOS ONE policies on sharing data and materials.